Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hawkins

Showing results (851-860 of 987) with videos related to

Pageof 99
Sort By:
Drug and Alcohol Dependence|June 15, 2015
Comparison of provider-documented and patient-reported brief intervention for unhealthy alcohol use in VA outpatientsGwen T Lapham, Anna D Rubinsky, Susan M Shortreed, et al.
Orthopaedic Journal of Sports Medicine|November 8, 2021
Professional Pitchers Display Differences in UCL Morphology and Elbow Gapping During Moving Valgus Stress Testing After UCL ReconstructionMichael J Kissenberth, Charles A Thigpen, Lane Brooks Bailey, et al.
Annals of Internal Medicine|April 1, 1988
Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trialR I Fisher, C A Coltman, J H Doroshow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Initial clinical trial of oral TAC-101, a novel retinoic acid receptor-alpha selective retinoid, in patients with advanced cancerNaiyer A Rizvi, John L Marshall, Elizabeth Ness, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Phase II trials of high-dose interleukin-2 and lymphokine-activated killer cells in advanced breast carcinoma and carcinoma of the lung, ovary, and pancreas and other tumorsJ A Sparano, R I Fisher, G R Weiss, et al.
Addiction Science & Clinical Practice|November 29, 2012
Feedback from recently returned veterans on an anonymous web-based brief alcohol interventionGwen T Lapham, Eric J Hawkins, Laura J Chavez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancerNaiyer A Rizvi, Gregory J Riely, Christopher G Azzoli, et al.
Inorganic Chemistry|July 12, 2026
Discovery at the Interface between Known Structure Types: The Layered Y<sub>10</sub>Ni<sub><i>x</i></sub>Cu<sub>1-<i>x</i></sub>Ti<sub>4</sub>O<sub>24</sub> FamilyNataliya L Gulay, Hai Lin, Batoul Almoussawi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1989
Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelinesK A Margolin, A A Rayner, M J Hawkins, et al.
Communications Biology|January 17, 2025
Understanding pectin cross-linking in plant cell wallsIrabonosi Obomighie, Iain J Prentice, Peter Lewin-Jones, et al.
Pageof 99

Showing results (851-860 of 987) with videos related to

Sort By:
Pageof 99
Drug and Alcohol Dependence|June 15, 2015
Comparison of provider-documented and patient-reported brief intervention for unhealthy alcohol use in VA outpatientsGwen T Lapham, Anna D Rubinsky, Susan M Shortreed, et al.
Orthopaedic Journal of Sports Medicine|November 8, 2021
Professional Pitchers Display Differences in UCL Morphology and Elbow Gapping During Moving Valgus Stress Testing After UCL ReconstructionMichael J Kissenberth, Charles A Thigpen, Lane Brooks Bailey, et al.
Annals of Internal Medicine|April 1, 1988
Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trialR I Fisher, C A Coltman, J H Doroshow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Initial clinical trial of oral TAC-101, a novel retinoic acid receptor-alpha selective retinoid, in patients with advanced cancerNaiyer A Rizvi, John L Marshall, Elizabeth Ness, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Phase II trials of high-dose interleukin-2 and lymphokine-activated killer cells in advanced breast carcinoma and carcinoma of the lung, ovary, and pancreas and other tumorsJ A Sparano, R I Fisher, G R Weiss, et al.
Addiction Science & Clinical Practice|November 29, 2012
Feedback from recently returned veterans on an anonymous web-based brief alcohol interventionGwen T Lapham, Eric J Hawkins, Laura J Chavez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancerNaiyer A Rizvi, Gregory J Riely, Christopher G Azzoli, et al.
Inorganic Chemistry|July 12, 2026
Discovery at the Interface between Known Structure Types: The Layered Y<sub>10</sub>Ni<sub><i>x</i></sub>Cu<sub>1-<i>x</i></sub>Ti<sub>4</sub>O<sub>24</sub> FamilyNataliya L Gulay, Hai Lin, Batoul Almoussawi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1989
Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelinesK A Margolin, A A Rayner, M J Hawkins, et al.
Communications Biology|January 17, 2025
Understanding pectin cross-linking in plant cell wallsIrabonosi Obomighie, Iain J Prentice, Peter Lewin-Jones, et al.
Pageof 99